A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.
Clinical trial NCT03564509 · COMPLETED
Trial details
- NCT number
- NCT03564509
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2019-10-21
- Enrollment
- 620
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.